Survival in relation to hospital type after resection or sorafenib treatment for hepatocellular carcinoma in The Netherlands

摘要

Background and objective: Despite an increase in recent years, hepatocellular carcinoma remains uncommon in the Netherlands. The aim of the current study is to explore potential effects of hospital type and volume on outcomes after resection or sorafenib in patients with hepatocellular carcinoma.